Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Product sales, net $ 24,429 $ 53,696
Cost of goods sold 13,420 18,608
Gross profit 11,009 35,088
Operating expenses:    
Research and development 2,943 5,877
Selling, general and administrative 30,658 46,451
Total Operating Expenses 33,601 52,328
Operating loss (22,592) (17,240)
Interest (income) expense, net 9 (15)
Loss before income taxes (22,601) (17,225)
Income tax benefit (317) (615)
Net loss $ (22,284) $ (16,610)
Earnings Per Share:    
Weighted average common shares outstanding, basic and diluted (in shares) 99,913 97,861
Net loss per common share , basic and diluted (in USD per share) $ (0.22) $ (0.17)
Revenue, Product and Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember